Benjamin Levi1, Aaron W James, Jason P Glotzbach, Derrick C Wan, George W Commons, Michael T Longaker. 1. Stanford and Los Angeles, Calif. From the Hagey Pediatric Regenerative Medicine Research Laboratory, Department of Surgery, Plastic and Reconstructive Surgery Division, Stanford University School of Medicine, and the Division of Plastic and Reconstructive Surgery, University of California, Los Angeles.
Abstract
BACKGROUND: Adipose-derived stromal cells hold promise for use in tissue regeneration. However, multiple facets of their biology remain unclear. The authors examined the variations in osteogenesis and adipogenesis in adipose-derived stromal cells between subcutaneous fat depots and potential molecular causes. METHODS: Adipose-derived stromal cells were isolated from human patients from subcutaneous fat depots, including arm, flank, thigh, and abdomen (n = 5 patients). Osteogenic and adipogenic differentiation was performed (alkaline phosphatase, alizarin red, and oil red O staining, and quantitative real-time polymerase chain reaction). Co-cultures were established to assess the paracrine effect of human adipose-derived stromal cells on mouse osteoblasts. Finally, HOX gene expression was analyzed by quantitative real-time polymerase chain reaction. RESULTS: Subcutaneous fat depots retain markedly different osteogenic and adipogenic potentials. Osteogenesis was most robust in adipose-derived stromal cells from the flank and thigh, as compared with those from the arm and abdomen (p < 0.05 by all markers examined). This was accompanied by elevations of BMP4 and BMPR1B (p < 0.05 by all markers examined). The osteogenic advantage of cells from the flank and thigh was again observed when analyzing the paracrine effects of these cells. Conversely, those cells isolated from the flank had a lesser ability to undergo adipogenic differentiation. Adipose-associated HOX genes were less expressed in flank-derived adipose-derived stromal cells. CONCLUSIONS: Variations exist between fat depots in terms of adipose-derived stromal cell osteogenic and adipogenic differentiation. Differences in HOX expression and bone morphogenetic protein signaling may underlie these observations. This study indicates that the choice of fat depot derivation of adipose-derived stromal cells may be an important one for future efforts in tissue engineering.
BACKGROUND: Adipose-derived stromal cells hold promise for use in tissue regeneration. However, multiple facets of their biology remain unclear. The authors examined the variations in osteogenesis and adipogenesis in adipose-derived stromal cells between subcutaneous fat depots and potential molecular causes. METHODS: Adipose-derived stromal cells were isolated from humanpatients from subcutaneous fat depots, including arm, flank, thigh, and abdomen (n = 5 patients). Osteogenic and adipogenic differentiation was performed (alkaline phosphatase, alizarin red, and oil red O staining, and quantitative real-time polymerase chain reaction). Co-cultures were established to assess the paracrine effect of human adipose-derived stromal cells on mouse osteoblasts. Finally, HOX gene expression was analyzed by quantitative real-time polymerase chain reaction. RESULTS: Subcutaneous fat depots retain markedly different osteogenic and adipogenic potentials. Osteogenesis was most robust in adipose-derived stromal cells from the flank and thigh, as compared with those from the arm and abdomen (p < 0.05 by all markers examined). This was accompanied by elevations of BMP4 and BMPR1B (p < 0.05 by all markers examined). The osteogenic advantage of cells from the flank and thigh was again observed when analyzing the paracrine effects of these cells. Conversely, those cells isolated from the flank had a lesser ability to undergo adipogenic differentiation. Adipose-associated HOX genes were less expressed in flank-derived adipose-derived stromal cells. CONCLUSIONS: Variations exist between fat depots in terms of adipose-derived stromal cell osteogenic and adipogenic differentiation. Differences in HOX expression and bone morphogenetic protein signaling may underlie these observations. This study indicates that the choice of fat depot derivation of adipose-derived stromal cells may be an important one for future efforts in tissue engineering.
Authors: Aaron W James; Benjamin Levi; Emily R Nelson; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker Journal: Stem Cells Dev Date: 2010-10-17 Impact factor: 3.272
Authors: Michael T Chung; Andrew S Zimmermann; Kevin J Paik; Shane D Morrison; Jeong S Hyun; David D Lo; Adrian McArdle; Daniel T Montoro; Graham G Walmsley; Kshemendra Senarath-Yapa; Michael Sorkin; Robert Rennert; Hsin-Han Chen; Andrew S Chung; Dean Vistnes; Geoffrey C Gurtner; Michael T Longaker; Derrick C Wan Journal: Stem Cells Transl Med Date: 2013-09-09 Impact factor: 6.940
Authors: Aaron W James; Angel Pan; Michael Chiang; Janette N Zara; Xinli Zhang; Kang Ting; Chia Soo Journal: Biochem Biophys Res Commun Date: 2011-06-23 Impact factor: 3.575
Authors: Pietro Gentile; Augusto Orlandi; Maria Giovanna Scioli; Camilla Di Pasquali; Ilaria Bocchini; Valerio Cervelli Journal: Stem Cells Transl Med Date: 2012-02-22 Impact factor: 6.940
Authors: Aaron W James; Shen Pang; Asal Askarinam; Mirko Corselli; Janette N Zara; Raghav Goyal; Le Chang; Angel Pan; Jia Shen; Wei Yuan; David Stoker; Xinli Zhang; John S Adams; Kang Ting; Chia Soo Journal: Stem Cells Dev Date: 2012-02-22 Impact factor: 3.272
Authors: Benjamin Levi; Derrick C Wan; Jason P Glotzbach; Jeong Hyun; Michael Januszyk; Daniel Montoro; Michael Sorkin; Aaron W James; Emily R Nelson; Shuli Li; Natalina Quarto; Min Lee; Geoffrey C Gurtner; Michael T Longaker Journal: J Biol Chem Date: 2011-09-23 Impact factor: 5.157
Authors: Soonchul Lee; Jia Shen; Hsin Chuan Pan; Swati Shrestha; Greg Asatrian; Alan Nguyen; Carolyn Meyers; Vi Nguyen; Min Lee; Chia Soo; Kang Ting; Aaron W James Journal: Tissue Eng Part A Date: 2016-10-18 Impact factor: 3.845
Authors: Aaron W James; Benjamin Levi; George W Commons; Jason Glotzbach; Michael T Longaker Journal: Plast Reconstr Surg Date: 2010-09 Impact factor: 4.730